Compound ID | 347
Class: Beta-lactam
| Agent Type: | Semisynthetic; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against Gram-positives including ofloxacin-resistant Staphylococcus aureus |
| Description: | Kim S, Choi K, Lee J, et al. Synthesis and biological activities of Cephalosporin antibiotic YJP-40102. 45th-Intersci-Conf-Antimicrob-Agents-Chemother 2005;202 |
| Institute where first reported: | Yungjin Pharmaceuticals Co., Ltd, South Korea |
| Year first mentioned: | 2005 |
| Development status: | Experimental |
| External links: |